Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus
- PMID:27059595
- PMCID: PMC4868781
- DOI: 10.4049/jimmunol.1500418
Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus
Abstract
Apoptotic debris, autoantibody, and IgG-immune complexes (ICs) have long been implicated in the inflammation associated with systemic lupus erythematosus (SLE); however, it remains unclear whether they initiate immune-mediated events that promote disease. In this study, we show that PBMCs from SLE patients experiencing active disease, and hematopoietic cells from lupus-prone MRL/lpr and NZM2410 mice accumulate markedly elevated levels of surface-bound nuclear self-antigens. On dendritic cells (DCs) and macrophages (MFs), the self-antigens are part of IgG-ICs that promote FcγRI-mediated signal transduction. Accumulation of IgG-ICs is evident on ex vivo myeloid cells from MRL/lpr mice by 10 wk of age and steadily increases prior to lupus nephritis. IgG and FcγRI play a critical role in disease pathology. Passive transfer of pathogenic IgG into IgG-deficient MRL/lpr mice promotes the accumulation of IgG-ICs prior to significant B cell expansion, BAFF secretion, and lupus nephritis. In contrast, diminishing the burden IgG-ICs in MRL/lpr mice through deficiency in FcγRI markedly improves these lupus pathologies. Taken together, our findings reveal a previously unappreciated role for the cell surface accumulation of IgG-ICs in human and murine lupus.
Copyright © 2016 by The American Association of Immunologists, Inc.
Figures





Similar articles
- A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.Ji J, et al.Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):411-9. doi: 10.1093/abbs/gmw017.Acta Biochim Biophys Sin (Shanghai). 2016.PMID:27121231Free PMC article.
- Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.Cash H, et al.J Rheumatol. 2010 Jan;37(1):60-70. doi: 10.3899/jrheum.090194. Epub 2009 Dec 1.J Rheumatol. 2010.PMID:19955044
- Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.Jiang C, Zhao ML, Scearce RM, Diaz M.Jiang C, et al.Arthritis Rheum. 2011 Apr;63(4):1086-96. doi: 10.1002/art.30230.Arthritis Rheum. 2011.PMID:21225690Free PMC article.
- Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.Reilly CM, Gilkeson GS.Reilly CM, et al.Immunol Res. 2002;25(2):143-53. doi: 10.1385/ir:25:2:143.Immunol Res. 2002.PMID:11999168Review.
- The central and multiple roles of B cells in lupus pathogenesis.Chan OT, Madaio MP, Shlomchik MJ.Chan OT, et al.Immunol Rev. 1999 Jun;169:107-21. doi: 10.1111/j.1600-065x.1999.tb01310.x.Immunol Rev. 1999.PMID:10450512Review.
Cited by
- Omega-3 Docosahexaenoic Acid (DHA) Impedes Silica-Induced Macrophage Corpse Accumulation by Attenuating Cell Death and Potentiating Efferocytosis.Rajasinghe LD, Chauhan PS, Wierenga KA, Evered AO, Harris SN, Bates MA, Gavrilin MA, Pestka JJ.Rajasinghe LD, et al.Front Immunol. 2020 Oct 6;11:2179. doi: 10.3389/fimmu.2020.02179. eCollection 2020.Front Immunol. 2020.PMID:33123123Free PMC article.
- Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.Gatto M, Wiedemann A, Nomovi N, Reiter K, Schrezenmeier E, Rose T, Szelinski F, Lino AC, Valentino S, Ghirardello A, Dörner T, Doria A.Gatto M, et al.Front Immunol. 2019 Jan 25;10:29. doi: 10.3389/fimmu.2019.00029. eCollection 2019.Front Immunol. 2019.PMID:30740098Free PMC article.
- BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis.Kang S, Fedoriw Y, Brenneman EK, Truong YK, Kikly K, Vilen BJ.Kang S, et al.J Immunol. 2017 Apr 1;198(7):2602-2611. doi: 10.4049/jimmunol.1600281. Epub 2017 Feb 24.J Immunol. 2017.PMID:28235864Free PMC article.
- Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus.Wen L, Zhang B, Wu X, Liu R, Fan H, Han L, Zhang Z, Ma X, Chu CQ, Shi X.Wen L, et al.Front Immunol. 2023 Feb 15;14:1093208. doi: 10.3389/fimmu.2023.1093208. eCollection 2023.Front Immunol. 2023.PMID:36875095Free PMC article.Review.
- Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus.Monteith AJ, Kang S, Scott E, Hillman K, Rajfur Z, Jacobson K, Costello MJ, Vilen BJ.Monteith AJ, et al.Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2142-51. doi: 10.1073/pnas.1513943113. Epub 2016 Mar 28.Proc Natl Acad Sci U S A. 2016.PMID:27035940Free PMC article.
References
- Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311–318. - PubMed
- Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 2006;28:119–130. - PubMed
- Bardana EJ, Jr, Harbeck RJ, Hoffman AA, Pirofsky B, Carr RI. The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE) Am J Med. 1975;59:515–522. - PubMed
- Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell. 2010;140:619–630. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases